Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Network Comparison Type Value Type Interaction Map Filtered green network_comparison red
Results: HTML CSV LaTeX Showing element 1 to 50 of 16578 in total 
Value Type: Measured
Filtered: 1

\def\wcA{0.125\textwidth}
\def\wcB{0.125\textwidth}
\def\wcC{0.125\textwidth}
\def\wcD{0.125\textwidth}
\def\wcE{0.125\textwidth}
\def\wcF{0.125\textwidth}
\def\wcG{0.125\textwidth}
\begin{longtable}{|c|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Network Comparison Type\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Interaction Map\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
red\vspace{3pt}}\\
\hline
\hline
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
carboxypeptidase d precursor (ec 3.4.17.-) (gp180). [source:swissprot;acc:o75976]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
32028.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
8870.5\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
40899\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
lysosome-associated membrane glycoprotein 1 precursor (lamp-1) (cd107a antigen). [source:swissprot;acc:p11279]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
543.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
4.4149\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
2399.5\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
mannosyl-oligosaccharide 1,2-alpha-mannosidase ib (ec 3.2.1.113) (processing alpha-1,2-mannosidase ib) (alpha-1,2-mannosidase ib) (mannosidase alpha class 1a member 2). [source:swissprot;acc:o60476]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
33356.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
8126\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
41482.5\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
rad50-interacting protein 1. [source:refseq;acc:nm\_021930]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
2394.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
5.31521\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
450.5\vspace{3pt}}\\\hline
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
2\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
28s ribosomal protein s17, mitochondrial precursor (mrp-s17) (hspc011). [source:swissprot;acc:q9y2r5]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
28492\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
7307\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
21185\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
cell division protein kinase 4 (ec 2.7.1.37) (cyclin-dependent kinase 4) (psk-j3). [source:swissprot;acc:p11802]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
543.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
4.4149\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
2399.5\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
cytohesin 1 (sec7 homolog b2-1). [source:swissprot;acc:q15438]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
33356.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
8126\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
41482.5\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
rho-related btb domain-containing protein 2 (deleted in breast cancer 2 gene protein) (p83). [source:swissprot;acc:q9byz6]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&&\parbox{\wcE}{\vspace{3pt}\noindent
2394.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
5.31521\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
450.5\vspace{3pt}}\\\cline{1-2}\cline{4-7}
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
3\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cell division protein kinase 6 (ec 2.7.1.37) (serine/threonine protein kinase plstire). [source:swissprot;acc:q00534]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
543.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
4.4149\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
2399.5\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
cytohesin 2 (arf nucleotide-binding site opener) (arno protein) (arf exchange factor). [source:swissprot;acc:q99418]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
33356.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
8126\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
41482.5\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
homeobox protein hlx1 (homeobox protein hb24). [source:swissprot;acc:q14774]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
698.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
3.71868\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
2597.5\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
mitochondrial solute carrier protein. [source:refseq;acc:nm\_145305]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
28492\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
7307\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
21185\vspace{3pt}}\\\cline{1-2}\cline{5-7}
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
4\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
bestrophin (vitelliform macular dystrophy protein) (tu15b). [source:swissprot;acc:o76090]\vspace{3pt}}&&&\parbox{\wcE}{\vspace{3pt}\noindent
43509.4\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
7035.1\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
36474.3\vspace{3pt}}\\\cline{2-2}\cline{4-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
cytohesin 4. [source:swissprot;acc:q9uia0]\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
33356.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
8126\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
41482.5\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
hbs1-like. [source:refseq;acc:nm\_006620]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&&\parbox{\wcE}{\vspace{3pt}\noindent
698.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
3.71868\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
2597.5\vspace{3pt}}\\\cline{2-2}\cline{4-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
lysosome-associated membrane glycoprotein 2 precursor (lamp-2) (cd107b antigen). [source:swissprot;acc:p13473]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
543.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
4.4149\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
2399.5\vspace{3pt}}\\\hline
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
5\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cytohesin 3 (arf nucleotide-binding site opener 3) (arno3 protein) (general receptor of phosphoinositides 1) (grp1). [source:swissprot;acc:o43739]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
33356.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
8126\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
41482.5\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
junctophilin 3 (junctophilin type 3) (jp-3). [source:swissprot;acc:q8wxh2]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&&\parbox{\wcE}{\vspace{3pt}\noindent
339.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
3.39764\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1153.5\vspace{3pt}}\\\cline{2-2}\cline{4-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
oxysterol binding protein-related protein 6 (osbp-related protein 6) (orp-6). [source:swissprot;acc:q9bzf3]\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
2113.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
2.86965\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
736.5\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
vitelliform macular dystrophy 2-like protein 2. [source:refseq;acc:nm\_153274]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
43503.3\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
7034\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
36469.3\vspace{3pt}}\\\hline
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
6\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
junctophilin 2 (junctophilin type 2) (jp-2). [source:swissprot;acc:q9br39]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
339.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
3.39764\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1153.5\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
nuclear dna-binding protein; small unique nuclear receptor corepressor; c1d dna-binding protein. [source:refseq;acc:nm\_006333]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
43368.8\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
7008.5\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
36360.3\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
oxysterol binding protein-related protein 3 (osbp-related protein 3) (orp-3). [source:swissprot;acc:q9h4l5]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
2113.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
2.86965\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
736.5\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
putative glialblastoma cell differentiation-related; putative glialblastoma cell differentiation-related protein. [source:refseq;acc:nm\_016172]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
36927.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
7563\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
44490.5\vspace{3pt}}\\\cline{1-2}\cline{5-7}
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
7\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
28s ribosomal protein s17, mitochondrial precursor (mrp-s17) (hspc011). [source:swissprot;acc:q9y2r5]\vspace{3pt}}&&&\parbox{\wcE}{\vspace{3pt}\noindent
28492\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
7307\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
21185\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
oxysterol binding protein-related protein 7 (osbp-related protein 7) (orp-7). [source:swissprot;acc:q9bzf2]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2113.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
2.86965\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
736.5\vspace{3pt}}\\\cline{2-2}\cline{4-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
sphingomyelin phosphodiesterase 2 (ec 3.1.4.12) (neutral sphingomyelinase) (nsmase) (n-smase) (lyso-platelet activating factor- phospholipase c) (lyso-paf-plc). [source:swissprot;acc:o60906]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
339.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
3.39764\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1153.5\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
vitelliform macular dystrophy 2-like protein 1. [source:refseq;acc:nm\_017682]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
43368.8\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
7008.5\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
36360.3\vspace{3pt}}\\\hline
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
8\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
db83 protein. [source:swissprot;acc:p57088]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
339.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
3.39764\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1153.5\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
deoxyribonuclease ii beta isoform 1 precursor; deoxyribonuclease ii beta; endonuclease dlad. [source:refseq;acc:nm\_021233]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
39358.1\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
6246.7\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
33111.4\vspace{3pt}}\\\cline{2-2}\cline{4-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
pantothenate kinase 1 (ec 2.7.1.33) (pantothenic acid kinase 1) (hpank1) (hpank). [source:swissprot;acc:q8te04]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
28492\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
7307\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
21185\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
phosphatidylinositol-glycan biosynthesis, class f protein (pig-f). [source:swissprot;acc:q07326]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
5058.5\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.54317\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcG}{\vspace{3pt}\noindent
3278\vspace{3pt}}}\\\cline{1-2}
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
9\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
n33 protein. [source:swissprot;acc:q13454]\vspace{3pt}}&&&&&\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
pantothenate kinase 2, mitochondrial precursor (ec 2.7.1.33) (pantothenic acid kinase 2) (hpank2). [source:swissprot;acc:q9bz23]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
28492\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
7307\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
21185\vspace{3pt}}\\\cline{2-2}\cline{4-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
sperm associated antigen 7. [source:refseq;acc:nm\_004890]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
19280.8\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
4037.2\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
23318\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
tob2 protein (transducer of erbb-2 2). [source:swissprot;acc:q14106]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1281.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
3.21581\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
398.5\vspace{3pt}}\\\cline{1-2}\cline{4-7}
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
10\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
implantation-associated protein. [source:refseq;acc:nm\_032121]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5058.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.54317\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
3278\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
pantothenate kinase 3 (ec 2.7.1.33) (pantothenic acid kinase 3) (hpank3). [source:swissprot;acc:q9h999]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
28492\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
7307\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
21185\vspace{3pt}}\\\cline{2-2}\cline{4-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
putative glialblastoma cell differentiation-related; putative glialblastoma cell differentiation-related protein. [source:refseq;acc:nm\_016172]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
17265.4\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
2232.7\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
19498.1\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
tob1 protein (transducer of erbb-2 1). [source:swissprot;acc:p50616]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1281.5\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
3.21581\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcG}{\vspace{3pt}\noindent
398.5\vspace{3pt}}}\\\cline{1-2}
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
11\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
dab2 interacting protein; ngap-like protein; doc-2/dab2 interactive protein. [source:refseq;acc:nm\_032552]\vspace{3pt}}&&&&&\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
mitochondrial solute carrier protein. [source:refseq;acc:nm\_145305]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&&\parbox{\wcE}{\vspace{3pt}\noindent
28492\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
7307\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
21185\vspace{3pt}}\\\cline{2-2}\cline{4-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
retinoblastoma-associated factor 600. [source:refseq;acc:nm\_020765]\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
9368.87\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
2112.16\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
7256.71\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
thyroid receptor interacting protein 8 (trip-8) (fragment). [source:swissprot;acc:q15652]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&&\parbox{\wcE}{\vspace{3pt}\noindent
2950.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.53861\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1917.64\vspace{3pt}}\\\cline{1-2}\cline{4-7}
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
12\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cytoplasmic polyadenylation element binding protein 4. [source:refseq;acc:nm\_030627]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1281.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
3.21581\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
398.5\vspace{3pt}}\\\cline{2-2}\cline{4-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
gbp protein isoform a. [source:refseq;acc:nm\_017870]\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
2954.24\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.5371\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1921.96\vspace{3pt}}\\\cline{2-3}\cline{5-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
homeobox protein hox-c4 (hox-3e) (cp19). [source:swissprot;acc:p09017]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&&\parbox{\wcE}{\vspace{3pt}\noindent
17572.7\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
2108.6\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
15464.1\vspace{3pt}}\\\cline{2-2}\cline{4-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
nuclear dna-binding protein; small unique nuclear receptor corepressor; c1d dna-binding protein. [source:refseq;acc:nm\_006333]\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
40795.8\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
6604.9\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
34190.9\vspace{3pt}}\\\cline{1-3}\cline{5-7}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
13\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cytoplasmic polyadenylation element binding protein 3. [source:refseq;acc:nm\_014912]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
1281.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
3.21581\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
398.5\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
homeobox protein hox-b4 (hox-2f) (hox-2.6). [source:swissprot;acc:p17483]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
17572.7\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
2108.6\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
15464.1\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/